Eagle Pharmaceuticals
EGRX
#10068
Rank
NZ$21.42 M
Marketcap
$1.65
Share price
-5.50%
Change (1 day)
-81.15%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total debt

Total debt on the balance sheet as of June 2023 : NZ$0.12 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total debt is NZ$0.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eagle Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)

Total debt by year

Year Total debt Change
2022-12-31NZ$0.10 B155.81%
2021-12-31NZ$39.4 M-17%
2020-12-31NZ$47.47 M-23.05%
2019-12-31NZ$61.7 M-6.79%
2018-12-31NZ$66.19 M-1.6%
2017-12-31NZ$67.27 M
2013-09-30N/A-100%
2012-09-30NZ$10.32 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$64.08 B 51,054.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.28 B 29,664.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$54.67 B 43,547.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$31.62 B 25,144.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$105.13 B 83,819.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$58.85 B 46,879.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$89.56 B 71,393.40%๐Ÿ‡บ๐Ÿ‡ธ USA